Elevance Health IncHigher-than-expected benefit expense ratio in Q2 2026, despite beating earnings and raising guidance, drove 8% share drop.
Elevance Health shares fell about 8% in premarket trading after the insurer reported a higher-than-expected benefit expense ratio in its second quarter of 2026, sending shares of Molina Healthcare, Centene, and Oscar Health lower. The benefit expense ratio, which measures the proportion of premiums paid out for medical care, rose 80 basis points year-over-year to 89.7%, exceeding the 90.15% projected by analysts according to LSEG data. Elevance attributed the increase mainly to rising medical cost trends in its Government businesses. Despite beating earnings estimates with adjusted earnings per share of $7.45 and raising its full-year adjusted EPS guidance to at least $27.00 from $26.75, total operating revenue grew only about 1% year-over-year to $49.8 billion, while total medical membership dropped roughly 2% to about 44.9 million amid declines in Medicaid and Medicare enrollees.
Elevance Health IncHigher-than-expected benefit expense ratio in Q2 2026, despite beating earnings and raising guidance, drove 8% share drop.
Centene CorpMentioned as peer dragged down by Elevance's rising benefit expense ratio, indicating sector-wide medical cost pressure.
Molina Healthcare IncMentioned as peer dragged down by Elevance's rising benefit expense ratio, indicating sector-wide medical cost pressure.
Oscar Health IncMentioned as peer dragged down by Elevance's rising benefit expense ratio, indicating sector-wide medical cost pressure.